This premier online event brings together leading international experts to showcase the latest breakthroughs in liquid biopsy research and its clinical translation for cancer diagnostics and precision medicine.
Key highlights include:
- State-of-the-art overviews and industry perspectives.
- Cutting-edge topics including methylation markers with digital PCR, ctDNA in colorectal cancer, gene fusion detection, liquid biopsy for brain tumors, point-of-care diagnostics, pancreatic cancer stratification, and CTC apheresis for functional and single-cell oncology.
- A strong focus on bridging research to real-world clinical practice for improved early detection, disease monitoring, prognosis, treatment selection, and personalized patient care.
Featuring pioneering figures such as Prof. Klaus Pantel (widely recognized as one of the founders of the liquid biopsy field, with landmark contributions to circulating tumor cells and the concept of liquid biopsy), alongside other internationally renowned experts including Catherine Alix-Panabières, Dr. Jürgen Scheuenpflug, Valerie Taly, Sven Borchmann, Leonora Balaj, PhD, Stefano Cinti, Milana Frenkel-Morgenstern, Prof. Dr. med. Georg Weber, Remond Fijneman, and Melanie Janning, whose work continues to advance liquid biopsy as a cornerstone of modern precision oncology.
Full program details: https://liquidbio.ircconferences.net/program
Join us on February 10, 2026 (12:30 PM – 6:40 PM, Central European Time) to hear directly from the experts driving clinical translation across multiple cancer types and shaping the future of precision medicine.
Register now: https://liquidbio.ircconferences.net/register
We look forward to welcoming you and exploring the future of liquid biopsy together!
